Psivant Therapeutics is advancing a paradigm shift in biotechnology by pioneering a physics-driven approach to drug design that is tightly coupled to chemistry and biology research and development. Our QUAISAR platform is purpose-built to develop novel small molecule therapeutics to address biologically and genetically validated, but previously intractable, protein targets.

Biotechnology

Psivant Therapeutics

Woody Sherman

Create Your Own Role!

Finith Jernigan

Camil Sayegh

Lynn Grice

Thomas Schultz

Vishal Sindhava

Evan Chiswick

Rafal Wiewiora

Neil Swami

The Scientific Research and Development team at Psivant Therapeutics is dedicated to leveraging cutting-edge computational and experimental techniques to innovate small molecule therapeutics. By integrating expertise in physics, chemistry, and biology, the team drives the QUAISAR platform to tackle challenging protein targets, enabling breakthroughs in drug design and advancing the company's mission to address previously intractable diseases.

Scientific Research and Development

Leadership Team

Biology and Molecular Sciences

Scientific Research and Development

About

Team members

Other teams at Psivant Therapeutics

Leadership Team

Biology and Molecular Sciences